Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4263179
[patent_doc_number] => 06204432
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'PA28 modified transgenic mice'
[patent_app_type] => 1
[patent_app_number] => 9/386746
[patent_app_country] => US
[patent_app_date] => 1999-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8233
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204432.pdf
[firstpage_image] =>[orig_patent_app_number] => 386746
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/386746 | PA28 modified transgenic mice | Aug 30, 1999 | Issued |
Array
(
[id] => 1567971
[patent_doc_number] => 06376743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Mammalian transgenesis by intracytoplasmic sperm injection'
[patent_app_type] => B1
[patent_app_number] => 09/371648
[patent_app_country] => US
[patent_app_date] => 1999-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 13129
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09371648
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/371648 | Mammalian transgenesis by intracytoplasmic sperm injection | Aug 9, 1999 | Issued |
Array
(
[id] => 7640398
[patent_doc_number] => 06395515
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Directed switch-mediated DNA recombination'
[patent_app_type] => B1
[patent_app_number] => 09/369635
[patent_app_country] => US
[patent_app_date] => 1999-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 15
[patent_no_of_words] => 12165
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395515.pdf
[firstpage_image] =>[orig_patent_app_number] => 09369635
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/369635 | Directed switch-mediated DNA recombination | Aug 5, 1999 | Issued |
Array
(
[id] => 6722540
[patent_doc_number] => 20030056230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'EXPRESSION OF HUMAN ESTROGEN RECEPTORS IN TRANSGENIC MICE'
[patent_app_type] => new
[patent_app_number] => 09/365614
[patent_app_country] => US
[patent_app_date] => 1999-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8241
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20030056230.pdf
[firstpage_image] =>[orig_patent_app_number] => 09365614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/365614 | Expression of human estrogen receptors in transgenic mice | Aug 1, 1999 | Issued |
Array
(
[id] => 4269076
[patent_doc_number] => 06322962
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Sterol-regulated Site-1 protease and assays of modulators thereof'
[patent_app_type] => 1
[patent_app_number] => 9/360237
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 57
[patent_no_of_words] => 52301
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/322/06322962.pdf
[firstpage_image] =>[orig_patent_app_number] => 360237
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/360237 | Sterol-regulated Site-1 protease and assays of modulators thereof | Jul 22, 1999 | Issued |
Array
(
[id] => 1531149
[patent_doc_number] => 06410029
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => '2-methoxyestradiol-induced apoptosis in cancer cells'
[patent_app_type] => B1
[patent_app_number] => 09/351191
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 16084
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410029.pdf
[firstpage_image] =>[orig_patent_app_number] => 09351191
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/351191 | 2-methoxyestradiol-induced apoptosis in cancer cells | Jul 8, 1999 | Issued |
Array
(
[id] => 1148879
[patent_doc_number] => 06770479
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-03
[patent_title] => 'Anthrax vaccine'
[patent_app_type] => B1
[patent_app_number] => 09/350729
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9790
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770479.pdf
[firstpage_image] =>[orig_patent_app_number] => 09350729
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/350729 | Anthrax vaccine | Jul 8, 1999 | Issued |
Array
(
[id] => 1141162
[patent_doc_number] => 06777236
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-17
[patent_title] => 'Process for producing a neuronal host cell in vitro comprising regulatory sequences of the 2-subunit of the neuronal nicotinic acetylcholine receptor'
[patent_app_type] => B1
[patent_app_number] => 09/349925
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15219
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09349925
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/349925 | Process for producing a neuronal host cell in vitro comprising regulatory sequences of the 2-subunit of the neuronal nicotinic acetylcholine receptor | Jul 7, 1999 | Issued |
Array
(
[id] => 6722539
[patent_doc_number] => 20030056229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'NF-AT POLYPEPTIDES AND POLYNUCLEOTIDES'
[patent_app_type] => new
[patent_app_number] => 09/349058
[patent_app_country] => US
[patent_app_date] => 1999-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21180
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20030056229.pdf
[firstpage_image] =>[orig_patent_app_number] => 09349058
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/349058 | NF-AT POLYPEPTIDES AND POLYNUCLEOTIDES | Jul 6, 1999 | Abandoned |
Array
(
[id] => 1521986
[patent_doc_number] => 06414219
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Osteopontin knock-out mouse and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/340484
[patent_app_country] => US
[patent_app_date] => 1999-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 36
[patent_no_of_words] => 14058
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/414/06414219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09340484
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/340484 | Osteopontin knock-out mouse and methods of use thereof | Jun 29, 1999 | Issued |
09/339552 | GENE THERAPY FOR EFFECTOR CELL REGULATION | Jun 23, 1999 | Abandoned |
Array
(
[id] => 4357125
[patent_doc_number] => 06291740
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Transgenic animals'
[patent_app_type] => 1
[patent_app_number] => 9/329749
[patent_app_country] => US
[patent_app_date] => 1999-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29012
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291740.pdf
[firstpage_image] =>[orig_patent_app_number] => 329749
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/329749 | Transgenic animals | Jun 9, 1999 | Issued |
Array
(
[id] => 1393180
[patent_doc_number] => 06548737
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Transgenic mice deficient in natural killer cells'
[patent_app_type] => B1
[patent_app_number] => 09/312454
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 13957
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09312454
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/312454 | Transgenic mice deficient in natural killer cells | May 13, 1999 | Issued |
Array
(
[id] => 1536731
[patent_doc_number] => 06337392
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Lens transcriptional control elements and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/306042
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12256
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337392.pdf
[firstpage_image] =>[orig_patent_app_number] => 09306042
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/306042 | Lens transcriptional control elements and methods of use thereof | May 5, 1999 | Issued |
Array
(
[id] => 1587320
[patent_doc_number] => 06359194
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Compositions and methods for the treatment and diagnosis of cardiovascular disease'
[patent_app_type] => B1
[patent_app_number] => 09/288292
[patent_app_country] => US
[patent_app_date] => 1999-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 57244
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09288292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/288292 | Compositions and methods for the treatment and diagnosis of cardiovascular disease | Apr 7, 1999 | Issued |
Array
(
[id] => 1238471
[patent_doc_number] => 06685911
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Sensitization process for antigen-presenting cells and means for implementing the process'
[patent_app_type] => B1
[patent_app_number] => 09/267370
[patent_app_country] => US
[patent_app_date] => 1999-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 17
[patent_no_of_words] => 17966
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685911.pdf
[firstpage_image] =>[orig_patent_app_number] => 09267370
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/267370 | Sensitization process for antigen-presenting cells and means for implementing the process | Mar 14, 1999 | Issued |
09/268135 | INTERFERON ALPHA PLASMIDS AND DELIVERY SYSTEMS, AND METHODS OF MAKING AND USING THE SAME | Mar 11, 1999 | Abandoned |
09/254410 | MODEL FOR THE PAPILLOMA VIRUS INFECTION IN VIVO, CONSISTING OF THE SCID-BO MOUSE | Mar 4, 1999 | Abandoned |
09/257417 | NUCLEIC ACID MOLECULES ASSOCIATED WITH MELANOMA AND THYROID TUMORS | Feb 24, 1999 | Abandoned |
09/242296 | DELIVERY OF TOLEROGENIC ANTIGENS VIA EDIBLE PLANTS OR PLANT-DERIVED PRODUCTS | Feb 15, 1999 | Abandoned |